Discovery opens door to therapeutic development for FSH muscular dystrophy

Scientists are closer to understanding what triggers muscle damage in one of the most common forms of muscular dystrophy, called facioscapulohumeral muscular dystrophy (FSHD).

View full post on National Institutes of Health (NIH) News Releases

Leave a Reply

Your email address will not be published. Required fields are marked *